Clinical trials
Infections clinical trials
Below are recruiting infections clinical trials, each written for real people, not researchers. We’re tracking 1,763 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07301320RecruitingPhase 2
Epetraborole for Mycobacterium abscessus lung infection
This study tests an investigational medication called epetraborole for people with a chronic lung infection caused by Mycobacterium abscessus bacteria. You may be able to join if your infection is stable enough to delay standard treatment and you have symptoms like cough, fatigue, or weight loss.
Portland, OregonAges 18 years+ - NCT07303114Recruiting
HIV screening missed in general practice study
This study looks at missed chances for HIV testing in general doctor offices. It focuses on people who were diagnosed with HIV between 2021 and 2024.
StrasbourgAges 18 years+ - NCT07306156RecruitingPhase 1/Phase 2
GP350 CAR-T for Epstein-Barr virus related lymphoma
This trial tests a new treatment called GP350 CAR-T for patients with lymphoma (a type of blood cancer) that has come back or not responded to standard therapy, especially when linked to Epstein-Barr virus (EBV) infection. The therapy uses your own immune cells, modified to target and kill cancer cells carrying the GP350 protein from EBV.
Hefei, AnhuiAges 18–70 - NCT07306988RecruitingPhase 4
Treating H. pylori to improve metabolic syndrome
This trial tests whether treating H. pylori infection can help improve metabolic syndrome (a group of conditions like high blood sugar, abnormal cholesterol, and high blood pressure). It aims to understand how treatment changes your gut bacteria and overall health.
Nanjing, JiangsuAges 18–65 - NCT07308808RecruitingEarly Phase 1
Safety of a live bacteria solution for bladder infections
This trial tests if putting a live bacteria called Lactobacillus crispatus into the bladder is safe for people with spinal cord injury and neurogenic lower urinary tract dysfunction. It may help prevent urinary tract infections without antibiotics.
Washington D.C., District of ColumbiaAges 18 years+ - NCT07335874Recruiting
Hearing screening follow-up for congenital infection in newborns
This study checks if babies who fail their newborn hearing test might have a hidden infection from birth. It looks for cytomegalovirus (CMV), a common virus that can affect hearing, using a simple test.
StrasbourgAges birth–1 month - NCT07335965Recruiting
Recurring Lyme disease after travel
This study looks at people who have had Lyme disease more than once after traveling abroad. It aims to understand the patterns of the infection and why it comes back.
StrasbourgAges 1 year+ - NCT07337993Recruiting
Fungal chest infection: washing the chest cavity
This study tests a chest-washing procedure (lavage) for people with a fungal infection in the space between the lung and chest wall. It aims to see if this extra step helps clear the infection before or instead of surgery.
Lahore, Punjab ProvinceAges Any age - NCT07342491RecruitingPhase 1
Testing dasatinib to shrink HIV reservoir
This trial tests whether the drug dasatinib can reduce the hidden HIV reservoir in people who have had their virus well-controlled on HIV medications for a long time. It may help move toward a cure by targeting the cells where HIV hides.
Chicago, IllinoisAges 18 years+ - NCT07342881RecruitingPhase 1
Single dose study of pevifoscorvir in people with kidney impairment
This study tests how a single dose of the study drug, pevifoscorvir, is processed in people with different levels of kidney function. It helps understand if the dose needs to be adjusted for people with kidney problems.
Orlando, FloridaAges 18–75 - NCT07343089Recruiting
Study of Lyme disease during anti-CD20 treatment in France
This study looks at people who got a serious form of Lyme disease while being treated with a type of biologic drug called an anti-CD20 (such as rituximab). The goal is to learn more about these cases and improve care. You may join if you had Lyme disease confirmed by a DNA test within two years of taking this medicine.
StrasbourgAges 1 year+ - NCT07343167Recruiting
Study of factors linked to death in certain strep blood infections
This study looks at people who had a bloodstream infection caused by a specific group of streptococcus bacteria (Streptococcus anginosus group). The goal is to understand what factors might be linked to death in these infections.
StrasbourgAges 18 years+ - NCT07344506RecruitingPhase 4
Cure H. pylori: New combination therapy for stomach infection
This trial tests a new combination of medications to treat H. pylori, a common stomach infection that can cause ulcers. It aims to find a more effective treatment with fewer side effects.
KarachiAges 18 years+ - NCT07345325RecruitingPhase 3
Comparing antibiotic treatments for heart valve infections
This trial tests whether a treatment without rifampin works as well as one with rifampin for a type of heart valve infection caused by staph bacteria. It aims to find a simpler and safer option for patients with an infected artificial heart valve.
Aix-les-BainsAges 18 years+ - NCT06210854RecruitingPhase 2
HPV16/18 Vaccine Trial for Cervical Lesions
This trial tests a new vaccine (pBI-11) given with a device that uses mild electric pulses to help the vaccine enter cells. It is for people who have HPV16 or 18 but no high-grade cervical changes.
Birmingham, AlabamaAges 18 years+ - NCT07051187RecruitingPhase 1
WGc0201 for chronic hepatitis B
This trial tests a new drug called WGc0201 in adults with chronic hepatitis B who have controlled their virus with standard antiviral pills. It aims to see if WGc0201 can further reduce hepatitis B surface antigen (HBsAg) levels.
Chengdu, SichuanAges 18–65 - NCT07346222Recruiting
San Matteo endocarditis patient study
This study looks at patients diagnosed with infective endocarditis (a serious infection of the heart's inner lining) to learn more about the condition and improve care. If you have been diagnosed with infective endocarditis at a specific hospital, you may be able to join.
Pavia, LombardyAges 18 years+ - NCT07356583Recruiting
Neonatal enterovirus infections in Italy
This study looks at enterovirus infections in newborn babies admitted to intensive care, focusing on one type called echovirus 11. It aims to better understand the virus and how it affects babies to improve care.
Pavia, LombardyAges 1 day–4 weeks - NCT07359651Recruiting
Study on factors linked to death in severe tissue infections
This study looks at what factors are linked to higher risk of death in patients hospitalized with a severe, flesh-eating infection called necrotizing soft tissue infection (NSTI). It aims to help doctors better identify and treat these dangerous infections.
CagliariAges 18 years+ - NCT07367412Recruiting
Zinc supplements for infection prevention in older hospital patients
This study tests whether giving zinc supplements to older patients (65+) in the hospital can help prevent infections. It is for patients at Herlev Hospital who are not already taking high doses of zinc or receiving certain specialized treatments.
Herlev, CopenhagenAges 65 years+ - NCT07368634RecruitingPhase 1/Phase 2
EBV-TCR-T cells for persistent EBV after stem cell transplant
This trial tests whether special immune cells (called EBV-TCR-T cells) can help clear the Epstein-Barr virus in people who still have high virus levels after a stem cell transplant. It's an experimental therapy for those whose virus hasn't responded to standard care.
BeijingAges 18–70 - NCT07368647Recruiting
Hyperbaric oxygen for radiation cystitis symptoms
This trial tests whether hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) can improve symptoms and reduce inflammation in people with bladder damage from past pelvic radiation. It compares patients with radiation cystitis to those without it.
Lebanon, New HampshireAges 18 years+ - NCT07370948Recruiting
Antibiotic resistance in rectal bacteria of PrEP users
This study looks at the bacteria found in the rectum of people who take PrEP. It checks if those bacteria are resistant to antibiotics.
Bologna, BolognaAges 18–45 - NCT07374094Recruiting
Understanding C. difficile infection and treatment effects
This study is tracking patients with a confirmed C. difficile infection to understand how the body responds and how treatments work. You may be asked to do follow-up visits for up to 5 years.
UmeåAges 18 years+
Hear when a new Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infections?
- Yes. Clin2 currently lists 1,763 recruiting infections studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infections trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infections trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.